Mucinous Carcinoma Of The Ovary
J. Brown, M. Frumovitz
Published 2017 · Medicine
Download PDFAnalyze on Scholarcy
Mucinous ovarian carcinoma is a rare tumor, but deserves separate attention, as its clinical behavior is quite different from other types of ovarian carcinoma. This has implications for both surgical therapy as well as adjuvant treatment.
This paper references
SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type
Michelle Moh (2016)
The risk of adverse pregnancy outcome after bariatric surgery: a nationwide register-based matched cohort study.
M. M. Kjær (2013)
Prevalence of Lymph Node Metastasis in Primary Mucinous Carcinoma of the Ovary
K. Schmeler (2010)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H. Risch (2001)
Ovarian cancer, version 2.2013: Featured updates to the NCCN guidelines
R. Morgan (2013)
A distinct molecular profile associated with mucinous epithelial ovarian cancer
V. Heinzelmann-Schwarz (2006)
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
M. Piccart (2000)
Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma.
L. Kelemen (2011)
Safety of Fertility-Sparing Surgery in Primary Mucinous Carcinoma of the Ovary
Jung-Yun Lee (2015)
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
W. Winter (2007)
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
M. Gemignani (2003)
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
J. McAlpine (2009)
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
D. Pectasides (2005)
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
J. Seidman (2004)
The role of appendectomy for mucinous ovarian neoplasms.
J. E. Lin (2013)
Pathologic evaluation of unknown primary cancer.
K. Oien (2009)
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.
J. Alexandre (2010)
Cytokeratins 7 and 20 in Primary and Secondary Mucinous Tumors of the Ovary: Analysis of Coordinate Immunohistochemical Expression Profiles and Staining Distribution in 179 Cases
R. Vang (2006)
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
M. Bookman (2009)
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
W. Mcguire (1996)
Diagnostic Criteria and Behavior of Ovarian Seromucinous (Endocervical-Type Mucinous and Mixed Cell-Type) Tumors: Atypical Proliferative (Borderline) Tumors, Intraepithelial, Microinvasive, and Invasive Carcinomas
H. Shappell (2002)
Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study
M. Simons (2015)
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
J. Brun (2008)
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
Robertson Mackenzie (2015)
Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype
P. Kelly (2010)
Laparoscopic surgery for large benign ovarian cysts.
G. Eltabbakh (2008)
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.
F. Muggia (2000)
Ovarian Intestinal Type Mucinous Borderline Tumors: Are We Ready for a Nomenclature Change?
Andres G Chiesa (2010)
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
J. Schilder (2002)
Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies
V. Beral (2012)
Relative Frequency of Primary Ovarian Neoplasms: A 10-Year Review
P. Koonings (1989)
International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma.
J. Trimbos (2003)
Clinicopathological characteristics of mucinous adenocarcinoma of the ovary.
M. Shimada (2009)
Mucinous tumours of the ovary
Jay D Naik (2011)
Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families
D. Evans (2008)
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
R. Bristow (2002)
Unmasking the complexities of mucinous ovarian carcinoma.
M. Frumovitz (2010)
Primary and Metastatic Mucinous Adenocarcinomas in the Ovaries: Incidence in Routine Practice With a New Approach to Improve Intraoperative Diagnosis
J. Seidman (2003)
Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
Y. Cho (2006)
Expression of Mesothelin, Fascin, and Prostate Stem Cell Antigen in Primary Ovarian Mucinous Tumors and Their Utility in Differentiating Primary Ovarian Mucinous Tumors From Metastatic Pancreatic Mucinous Carcinomas in the Ovary
D. Cao (2005)
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma
J. Ledermann (2014)
Mucinous Tumors of the Ovary: A Clinicopathologic Study of 196 Borderline Tumors (of Intestinal Type) and Carcinomas, Including an Evaluation of 11 Cases With `Pseudomyxoma Peritonei'
K. Lee (2000)
Combination chemotherapy of oxaliplatin and 5‐fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy
S. Sato (2009)
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study
S. Pignata (2008)
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I. Vergote (2001)
Cancer statistics, 2013
R. Siegel (2013)
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
S. Mok (1993)
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
M. Riopel (1999)
Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
D. Sarrió (2006)
Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.
V. Hess (2004)
A phase II study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma.
Y. Shimizu (1998)
Survival in ovarian cancer patients by histology and family history
J. Ji (2008)
Laparoscopic resection of massive ovarian mucinous cystadenoma.
Charles M. Leys (2012)
Fertility preservation in young women with epithelial ovarian cancer
J. Wright (2009)
Analysis of Gene Expression in Early-Stage Ovarian Cancer
S. Marchini (2008)
TP53 and ovarian cancer
M. Schuijer (2003)
A serum based analysis of ovarian epithelial tumorigenesis.
B. Nolen (2009)
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.
M. Anglesio (2013)
Targeting Src in Mucinous Ovarian Carcinoma
K. Matsuo (2011)
Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer
Jin-Young Park (2016)
Multicystic ovarian tumor weighing 156 lbs: the second largest tumor in Texas.
D. Tait (1997)
Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10-year study in a tertiary hospital of eastern India.
S. Mondal (2011)
The Distinction Between Primary and Metastatic Mucinous Carcinomas of the Ovary: Gross and Histologic Findings in 50 Cases
K. Lee (2003)
Mucinous Tumors of the Ovary: A Clinicopathologic Analysis of 75 Borderline Tumors (of Intestinal Type) and Carcinomas
I. Rodríguez (2002)
Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
H. Mackay (2010)